Disease | pulmonary hypertension |
Phenotype | C0011644|scleroderma |
Sentences | 10 |
PubMedID- 20335527 | The presence of the hla-b35 allele has emerged as an important risk factor for the development of isolated pulmonary hypertension in patients with scleroderma, however the mechanisms underlying this association have not been fully elucidated. |
PubMedID- 21548946 | Furthermore, it has been shown that gdf-15 serum levels are increased in scleroderma patients with pulmonary hypertension and gdf-15 protein was predominantly located in monocytes infiltrating the lung tissue [18]. |
PubMedID- 20973920 | Our goal is to identify differentially expressed genes in peripheral blood mononuclear cells in scleroderma patients with and without pulmonary hypertension as biomarkers of disease. |
PubMedID- 20862337 | The prevalence of pulmonary hypertension associated with scleroderma ranged from 4.9% to 38% as written in the accp guidelines. |
PubMedID- 23780636 | Clinical and laboratory features of scleroderma patients with pulmonary hypertension. |
PubMedID- 23042670 | We sought to assess the construct validity and responsiveness of the ucsd sobq in systemic sclerosis (ssc; scleroderma) patients with incident pulmonary hypertension (ph) and those at high risk of developing ph. |
PubMedID- 23130095 | [2] subsequently, a second epoprostenol trial for patients with pulmonary hypertension associated with scleroderma resulted in fda approval for that condition. |
PubMedID- 22836630 | The present study was aimed at testing the prevalence of anti-endothelial cell antibodies (aeca) in systemic scleroderma (ssc) patients with and without pulmonary hypertension (ph) and in relation to the presence of pulmonary fibrosis. |
PubMedID- 21597395 | Objective: to detect coronary artery disease in asymptomatic patients with systemic lupus erythematosus and scleroderma associated with pulmonary hypertension, and to determine whether it is focal or diffuse ischemia. |
PubMedID- 22549387 | Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. |
Page: 1